Background & Sources: Reglan exposure linked to Tardive Dyskinesia: mechanisms and evidence

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

In-depth resource

Reglan exposure linked to Tardive Dyskinesia: mechanisms and evidence Resource Guide

In-depth context and analysis on this topic for researchers and advocates.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

PubMed Central (PMC)

Reference: PubMed Central (PMC)

Authoritative source for clinical, regulatory, and public-health background reading.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.